New experience for Data MATRIX

New experience for Data MATRIX

Experience is probably one of the greatest assets any clinical research service supplier can have – and our team is passionate about that. At the beginning of the new year, we decided to take a look back at all our projects, update stats and share it with you. Today, our portfolio encompasses more than 130 projects; most of them are completed, while the other ones are ongoing trials. We have processed over 18 000 CRFs, about 73 000 queries and coded more than 100 000 terms.

We know how to manage clinical research trials in a variety of therapeutic areas, including neurology and psychiatry (35), oncology (28), infectious diseases (27), and many others. Most of our projects are complex phase III clinical trials which comprise more than one-third of all Data MATRIX portfolio. It may seem cliché, but we feel proud of our individual approach to every project we undertake.

We know how to collect and process any clinical data. We are experienced in successful report submissions to the Ministry of Healthcare, FDA and EMA. Out data management and biostatistics team is the most experienced in the region. We were the first in Russia to develop clinical trials software in collaboration with the best team of IT professionals. We are always the most demanding users of our software. Our software products undergo validation prior to being used in each project and comply with all local and international regulations such as CDISC and 21 CFR Part 11. Data MATRIX products provide access to data from any place at any time, as they are stored securely in a cloud platform in compliance with legislation.

Six out of top-10 leading pharmaceutical companies have already entrusted their product to Data MATRIX: Novartis, Roche, Johnson&Johnson, GlaxoSmithKline, AstraZeneca, Abbvie.